23 May New Chairman of the Board will accelerate US growth. Industry veteran Donald L. Deyo to play a pivotal role in LindaCare.
Leuven, Belgium / Hartford, Connecticut, May 23rd 2017 – LindaCare is pleased to announce the appointment of Donald L. Deyo into the new role of Chairman of the Board, with immediate effect.
Deyo is currently CEO of FemPulse, a company developing novel neuromodulation therapy for women suffering with overactive bladder. Don was previously the founding President and CEO of Medallion Therapeutics, Inc., an Alfred Mann Foundation company involved in targeted drug delivery therapies. He also founded the executive consultancy MedTech Execs, which provides strategic and operational services to medical device and pharmaceutical companies.
A former Medtronic executive, Deyo served in various executive roles in Cardiac Rhythm Management (CRM) and neuromodulation over an extended (29 year) career. Deyo currently serves on the boards of Nyxoah S.A. and TROD Medical. He was a board member for Sapiens Steering Brain Stimulation B.V. prior to acquisition of the company by Medtronic in 2014.
Deyo joins LindaCare at a pivotal point in their development. With the recent announcement of a dedicated customer support center in CT, success in the US is critical to maintaining the accelerated growth.
As LindaCare prepares to seek a second round of funding to underpin their US growth and enhance products globally (including the addition of features such as artificial intelligence (AI) and enhanced data analytics), Deyo will be instrumental in building relationships with venture capital organizations.
Deyo will also involve with the current US network of service delivery partners as well as seeking to identify potential new partners to support the rapidly growing US customer base.
Commenting on the appointment, Shahram Sharif, CEO of LindaCare said “We are extremely pleased to have someone with Don’s depth and breadth in the industry join us. The US market is incredibly important to us and we know that Don’s experience will support us in executing our aggressive growth plans.”
Deyo added “I am excited to be joining LindaCare at this pivotal point in their development. It is rare that an opportunity with a company so perfectly poised for the future comes along and I am very happy to be chosen. I look forward to working with the global LindaCare team and especially our CT-based staff and partners in the US.”
LindaCare NV/SA – the parent organization of LindaCare, Inc., a start-up company venture capital backed by Capricorn ICT Fund (www.capricorn.be), is specialised in the development of integrated remote patient monitoring software solutions for chronic disease management. The initial focus of LindaCare is patients with heart failure (HF) and cardiac arrhythmia, equipped with Cardiac Implanted Electronic Devices (CIED) for Cardiac Rhythm Management (CRM). The solution will subsequently be extended to other chronic disease domains integrating a wide range of remote monitored medical devices.
Back to News